A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (nolatrexed dihydrochloride) given by 10-day oral administration (Q30321809)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (nolatrexed dihydrochloride) given by 10-day oral administration |
scientific article |
Statements
1 reference
A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq (nolatrexed dihydrochloride) given by 10-day oral administration (English)
1 reference
Jodrell DI
1 reference
Bowman A
1 reference
Rye R
1 reference
Byrne B
1 reference
Boddy A
1 reference
Rafi I
1 reference
Taylor GA
1 reference
Johnston A
1 reference
Clendeninn NJ
1 reference
1 February 1999
1 reference
1 reference
915-920
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference